Cheerland Biomedicine (CLBiomed) is a prominent player in the pharmaceutical industry, dedicated to establishing a world-class biotech enterprise that offers a diverse range of products and services. The company focuses primarily on Bio-CDMO, highlighted by its ambitious project to construct the largest biologics development and manufacturing site globally, catering to the needs of biopharma companies. With a total planned capacity exceeding 1.3 million litres and a maximal bioreactor size of 20,000 litres, Cheerland Biomedicine is positioned to provide high-quality, affordable, and trusted Bio-CDMO services, all under the guidance of a world-class management team.

Services include:
- Active Pharmaceutical Ingredients
- Biopharmaceuticals
- Contract Manufacturing (CMO/CDMO)
- Cell & Gene Therapy
- Finished Dosage Formulation
- Packaging

Through its comprehensive offerings, Cheerland Biomedicine is committed to delivering exceptional value to its clients in the global biotech sector. For more information, please visit clbiomed.com.